Granahan Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-51,719
Closed -$9.87M 202
2020
Q2
$9.87M Sell
51,719
-60,407
-54% -$10.6M 0.36% 79
2020
Q1
$17.4M Sell
112,126
-162,741
-59% -$18.9M 0.94% 28
2019
Q4
$23M Sell
274,867
-148,488
-35% -$11.3M 1.06% 25
2019
Q3
$28.7M Buy
423,355
+52,394
+14% +$3.45M 1.58% 17
2019
Q2
$24.6M Buy
370,961
+61,473
+20% +$3.58M 1.22% 24
2019
Q1
$17.2M Buy
309,488
+16,173
+6% +$987K 0.92% 32
2018
Q4
$14.5M Sell
293,315
-84,820
-22% -$5.19M 1.03% 31
2018
Q3
$32.7M Sell
378,135
-194,094
-34% -$13.8M 1.77% 8
2018
Q2
$33.2M Sell
572,229
-220,342
-28% -$10.8M 2% 6
2018
Q1
$31.9M Buy
792,571
+154,853
+24% +$5.85M 2.31% 5
2017
Q4
$22.2M Buy
637,718
+198,217
+45% +$6.58M 1.75% 7
2017
Q3
$14.6M Buy
+439,501
New +$14.4M 1.22% 19

Other funds holding TDOC

Granahan Investment Management's TDOC Position: Q3 2020 in Review

Granahan Investment Management sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 51,719 shares — an estimated $9.87M sold.

Granahan Investment Management first reported a position in TDOC in Q3 2017 and held it in 12 quarters. The position peaked at $33.2M in Q2 2018. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Granahan Investment Management reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Granahan Investment Management sold 51,719 Teladoc Health shares in Q3 2020, an estimated $9.87M.
  • Granahan Investment Management first reported a position in Teladoc Health in Q3 2017 and held it in 12 quarters.
  • Granahan Investment Management's Teladoc Health position peaked at $33.2M in Q2 2018.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Granahan Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.